NCT05757219 2026-02-27
Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Recruiting
Clinical Trials
7 trialsNCT05852717 2026-01-12
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
Hoosier Cancer Research Network
Phase 2 Recruiting
NCT05621096 2025-09-25
Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma
University of Nebraska
Phase 1 Active not recruiting
NCT05507827 2025-09-16
Myeloablative Conditioning Orca-T & Allogeneic Donor-Derived CD19/CD22-CAR TCells in B-Cell ALL
Stanford University
Phase 1 Active not recruiting
NCT05281809 2025-01-13
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Phase 2 Recruiting
NCT06541327 2024-08-19
Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection
Ruijin Hospital
Recruiting
NCT06106776 2023-10-30
CARdio-Tox
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Unknown